Detalhe da pesquisa
1.
A real-world evidence study of nabiximols in multiple sclerosis patients with resistant spasticity: Analysis in relation to the newly described 'spasticity-plus syndrome'.
Eur J Neurol
; 29(9): 2744-2753, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35590453